13F reference period
Q3 2026
Security Snapshot
BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA) Institutional Ownership
CUSIP: 09077V100
13F Institutional Holders and Ownership History from Q3 2024 to Q3 2026
Institutions Reporting
67
Shares (Excl. Options)
10.46M
Full value: 10,456,570 · shares · 30 Sep 2026Price
$7.09
The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.00001 per share
- Symbol
- BIOA on Nasdaq
- All holders as of 30 Sep 2026
- Q3 2026
- Total 13F shares
- 10,456,570
- Total 13F value
- $73,804,520
- Portfolio coverage rank
- 0%
- Share change
- +2,103,796
- Value change
- +$6,608,826
- Number of holders
- 67
- Shares outstanding
- 44,435,037
- SEC-reported price per share
- $5.94
- Insider filing price
- $5.94
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- BIOA - BioAge Labs, Inc. - Common Stock, par value $0.00001 per share is tracked under CUSIP 09077V100.
- 67 institutions reported positions in Q3 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 150 to 67 between Q2 2026 and Q3 2026.
- SEC-reported value moved from to
$924.62M
Full value: $924,621,506 · USD · 30 Jun 2026.$73.8M
Full value: $73,804,520 · USD · 30 Sep 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 67 institutions filings for Q3 2026.
Security key
09077V100
13F reference period
Q3 2026
13F holders
67
13D/G owners
6
CIK / CUSIP context first
Open Q3 2026 holders
BIOA full holder history
BioAge Labs, Inc. SEC filings
BioAge Labs, Inc. company facts
BioAge Labs, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 09077V100:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
BIOA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Fortney Kristen | 7.2% | $48,279,538 | 2,704,736 | Kristen Fortney | 31 Dec 2025 | |||
| Cormorant Asset Management, LP | 5.4% | -16% | $59,382,628 | -$12,420,000 | 2,390,605 | -17% | Cormorant Asset Management, LP | 30 Jun 2026 |
| BlackRock, Inc. | 5% | $39,115,685 | 2,236,460 | BlackRock, Inc. | 31 Mar 2026 | |||
| Khosla Ventures VI, L.P. | 4% | $29,120,985 | 1,798,702 | VK Services, LLC | 15 May 2026 | |||
| RA CAPITAL MANAGEMENT, L.P. | 3.7% | $5,740,380 | 1,310,589 | RA Capital Management, L.P. | 31 Dec 2024 | |||
| ADAR1 Capital Management, LLC | 0.4% | -100% | $2,419,746 | -$32,157,900 | 135,560 | -93% | ADAR1 Capital Management, LLC | 31 Dec 2025 |
As of 30 Sep 2026,
67
institutional investors reported holding
shares of
BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA).
This represents
24%
of the company’s total
outstanding shares.
10.46M
Full value: 10,456,570 · shares · 30 Sep 202644.44M
Full value: 44,435,037 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
23%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 3.6% | 1,621,099 | +5% | 0% | $11,493,592 |
| STATE STREET CORP | 3% | 1,348,310 | +32% | 0% | $9,559,518 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.1% | 921,507 | -8.2% | 0% | $6,534,866 |
| Sands Capital Alternatives, LLC | 1.8% | 786,353 | 0% | 0.8% | $5,575,243 |
| Pivotal bioVenture Partners Investment Advisor LLC | 1.5% | 653,374 | 0% | 1.8% | $4,632,422 |
| RENAISSANCE TECHNOLOGIES LLC | 1.4% | 626,661 | +278% | 0.01% | $4,443,026 |
| MORGAN STANLEY | 1.2% | 532,070 | +88% | 0% | $3,772,376 |
| COSMIC MANAGEMENT, LLC | 1.1% | 501,833 | 0% | 1.1% | $3,557,996 |
| DIMENSIONAL FUND ADVISORS LP | 1.1% | 499,916 | +27% | 0% | $3,544,591 |
| Qube Research & Technologies Ltd | 1.1% | 483,993 | 0% | $3,431,510 | |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.91% | 406,096 | -0.99% | 0% | $2,879,221 |
| FRANKLIN TEMPLETON INC | 0.85% | 378,467 | +34% | 0% | $2,251,879 |
| Y-Intercept (Hong Kong) Ltd | 0.71% | 316,767 | +1979% | 0.05% | $2,245,878 |
| VANGUARD FIDUCIARY TRUST CO | 0.58% | 256,683 | +17% | 0% | $1,819,882 |
| BNP PARIBAS FINANCIAL MARKETS | 0.26% | 116,034 | 0% | $822,681 | |
| PROFUND ADVISORS LLC | 0.17% | 76,284 | +601% | 0.02% | $540,854 |
| AMERICAN CENTURY COMPANIES INC | 0.15% | 65,834 | +20% | 0% | $466,763 |
| FEDERATED HERMES, INC. | 0.14% | 63,060 | 0% | $447,095 | |
| Swiss National Bank | 0.14% | 62,900 | 0% | $445,961 | |
| Alessandra Capital Management, LLC | 0.14% | 60,199 | -36% | 0.3% | $426,815 |
| MIZUHO SECURITIES USA LLC | 0.14% | 60,000 | 0.01% | $522,618 | |
| Invesco Ltd. | 0.1% | 44,693 | -65% | 0% | $316,874 |
| PANAGORA ASSET MANAGEMENT INC | 0.1% | 44,493 | 0% | $315,455 | |
| STRS OHIO | 0.09% | 42,200 | +92% | 0% | $299,198 |
| Quadrature Capital Ltd | 0.09% | 40,719 | +330% | 0% | $288,698 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
9
Headline period
Q3 2026
Rows shown
1-9 of 9
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 10,456,570 | $73,804,520 | +$6,608,826 | $7.09 | 67 |
| 2026 Q2 | 37,731,680 | $924,621,506 | +$85,957,503 | $24.51 | 150 |
| 2026 Q1 | 34,288,673 | $599,230,651 | +$183,047,150 | $17.49 | 144 |
| 2025 Q4 | 23,662,525 | $314,117,431 | +$36,761,604 | $13.23 | 113 |
| 2025 Q3 | 21,259,082 | $125,003,330 | +$3,516,038 | $5.88 | 92 |
| 2025 Q2 | 20,716,453 | $85,559,282 | +$3,327,577 | $4.13 | 81 |
| 2025 Q1 | 20,278,591 | $76,157,053 | +$1,658,645 | $3.76 | 65 |
| 2024 Q4 | 19,641,111 | $113,720,000 | -$68,696,192 | $5.79 | 64 |
| 2024 Q3 | 20,709,688 | $430,774,211 | +$424,388,861 | $20.80 | 58 |